FNCH
Geode Capital Management’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-208,320
| Closed | -$81.9K | – | 4821 |
|
2023
Q1 | $81.9K | Sell |
208,320
-1,390
| -0.7% | -$546 | ﹤0.01% | 4403 |
|
2022
Q4 | $100K | Sell |
209,710
-470
| -0.2% | -$224 | ﹤0.01% | 4404 |
|
2022
Q3 | $351K | Buy |
210,180
+106,734
| +103% | +$178K | ﹤0.01% | 3915 |
|
2022
Q2 | $293K | Sell |
103,446
-56,979
| -36% | -$161K | ﹤0.01% | 4045 |
|
2022
Q1 | $806K | Buy |
160,425
+9,263
| +6% | +$46.5K | ﹤0.01% | 3713 |
|
2021
Q4 | $1.51M | Sell |
151,162
-2,387
| -2% | -$23.8K | ﹤0.01% | 3514 |
|
2021
Q3 | $2M | Buy |
153,549
+13,028
| +9% | +$169K | ﹤0.01% | 3352 |
|
2021
Q2 | $1.98M | Buy |
+140,521
| New | +$1.98M | ﹤0.01% | 3270 |
|